Blog Archives

PRESS RELEASE: GLNT Launches Parkinson’s Technology In Europe For Quantitative Assessments In Telemedicine

VIEW PRESS RELEASE [PDF]

13 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that they are launching the latest version of their medical device technology for assessing Parkinson’s disease next week at the Movement Disorders Society Congress in Dublin, Ireland.  The Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/  ] system includes patient-worn motion sensors and a tablet computer to quantitatively assess tremor,

Read more ›



PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of motor symptoms associated with movement disorders.  

Read more ›



PRESS RELEASE: GLNT Secures Over $4.5 Million in Funding to Fuel New Product Development for Parkinson’s Disease and Neuroscience Education

VIEW PRESS RELEASE [PDF]

April 24, 2012: Valley View, OH Great Lakes NeuroTechnologies announced today they have secured over $4.5 million is funding for new product development. The funding includes three new projects sponsored by the National Institutes of Health’s SBIR program.

Read more ›



PRESS RELEASE: GLNT Tackles Continuous Monitoring of Essential Tremor with Launch of Multi-Site Clinical Study

VIEW PRESS RELEASE [PDF]

April 5, 2012: Valley View, OH Great Lakes NeuroTechnologies announced today they have launched a multi-site clinical study to assess continuous monitoring of essential tremor (ET) using their Kinesia technology platform. A preliminary study published in 2011 in the journal Parkinsonism and Related Disorders demonstrated that patient-worn motion sensors could detect tremor type and quantify tremor severity during both standardized tasks and non-standardized activities of daily living performed in a laboratory.

Read more ›



PRESS RELEASE: GLNT Begins Clinical Study to Demonstrate High Sensitivity Motor Symptom Detection in Parkinson’s Disease

VIEW PRESS RELEASE [PDF]

March 23, 2012: Valley View, OH Great Lakes NeuroTechnologies announced today that they have begun a clinical study to assess the sensitivity of their Kinesia system to detect subtle motor function changes in patients with Parkinson’s disease (PD).

Read more ›



PRESS RELEASE: The University of Rochester and Great Lakes NeuroTechnologies launch new clinical study to develop ambulatory dyskinesia assessment system

VIEW PRESS RELEASE [PDF]

Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD motor symptoms including tremor and bradykinesia are typically treated with levodopa.

Read more ›



PRESS RELEASE: Great Lakes NeuroTechnologies’ KinetiSense technology used in Parkinson’s disease gait and balance study

VIEW PRESS RELEASE [PDF]

Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology was used in a clinical study to capture and quantify the effect of Deep Brain Stimulation (DBS) on gait and balance impairment in Parkinson’s disease (PD).

Read more ›



PRESS RELEASE: CLEVEMED LAUNCHES CLINICIAL STUDY MONITORING PARKINSON’S DISEASE MOTOR SYMPTOMS IN THE CLINIC AND AT HOME USING KINESIA™

VIEW PRESS RELEASE [PDF]

CLEVELAND, Ohio (January 28, 2009) – Cleveland Medical Devices Inc. (CleveMed) has launched a large scale multicenter clinical study to continue development and validation of Kinesia™, a compact wireless system for monitoring severity of Parkinson’s disease (PD) motor symptoms. Kinesia uses miniature motion sensors worn on the hand and wirelessly transmits motor symptom information to a PC.

Read more ›



Top